We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

IRIDEX Corp (IRIX) USD0.01

Sell:$3.03 Buy:$3.10 Change: $0.16 (5.03%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:$3.03
Buy:$3.10
Change: $0.16 (5.03%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:$3.03
Buy:$3.10
Change: $0.16 (5.03%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Contact details

Address:
1212 Terra Bella Ave
MOUNTAIN VIEW
94043-1824
United States
Telephone:
+1 (650) 9404700
Website:
https://www.iridex.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
IRIX
ISIN:
US4626841013
Market cap:
$51.68 million
Shares in issue:
16.25 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • David Bruce
    President, Chief Executive Officer, Director
  • Fuad Ahmad
    Interim Chief Financial Officer
  • Patrick Mercer
    Chief Operating Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.